A Phase 1/2 Study of ALKS 4230 Administered Intravenously as Monotherapy and in Combination with Pembrolizumab in Subjects with Advanced Solid Tumors- ARTISTRY-1
This Study is
No Longer Enrolling
Details
Age
Adult
Type of Study
Treatment
Locations
University of Colorado Hospital
Study ID
Protocol Number: 19-2532
More information available at ClinicalTrials.gov: NCT02799095
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers